268 related articles for article (PubMed ID: 34215227)
1. CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix.
Martini C; DeNichilo M; King DP; Cockshell MP; Ebert B; Dale B; Ebert LM; Woods A; Bonder CS
BMC Cancer; 2021 Jul; 21(1):765. PubMed ID: 34215227
[TBL] [Abstract][Full Text] [Related]
2. CD36 and Its Role in Regulating the Tumor Microenvironment.
Liao X; Yan S; Li J; Jiang C; Huang S; Liu S; Zou X; Zhang G; Zou J; Liu Q
Curr Oncol; 2022 Oct; 29(11):8133-8145. PubMed ID: 36354702
[TBL] [Abstract][Full Text] [Related]
3. Vasculogenic mimicry structures in melanoma support the recruitment of monocytes.
Tan LY; Cockshell MP; Moore E; Myo Min KK; Ortiz M; Johan MZ; Ebert B; Ruszkiewicz A; Brown MP; Ebert LM; Bonder CS
Oncoimmunology; 2022; 11(1):2043673. PubMed ID: 35295096
[TBL] [Abstract][Full Text] [Related]
4. Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome.
Tan LY; Mintoff C; Johan MZ; Ebert BW; Fedele C; Zhang YF; Szeto P; Sheppard KE; McArthur GA; Foster-Smith E; Ruszkiewicz A; Brown MP; Bonder CS; Shackleton M; Ebert LM
Oncotarget; 2016 Jul; 7(29):46492-46508. PubMed ID: 27340778
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.
Wei X; Chen Y; Jiang X; Peng M; Liu Y; Mo Y; Ren D; Hua Y; Yu B; Zhou Y; Liao Q; Wang H; Xiang B; Zhou M; Li X; Li G; Li Y; Xiong W; Zeng Z
Mol Cancer; 2021 Jan; 20(1):7. PubMed ID: 33397409
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
Aikins AR; Kim M; Raymundo B; Kim CW
Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
[TBL] [Abstract][Full Text] [Related]
7. Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.
Zhang W; Zhou P; Meng A; Zhang R; Zhou Y
J Cell Mol Med; 2018 Mar; 22(3):1743-1754. PubMed ID: 29164766
[TBL] [Abstract][Full Text] [Related]
8. Antibody-Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 Signaling.
Sankar AP; Cho HM; Shin SU; Sneh T; Ramakrishnan S; Elledge C; Zhang Y; Das R; Gil-Henn H; Rosenblatt JD
Cancer Res Commun; 2024 Mar; 4(3):738-756. PubMed ID: 38315147
[TBL] [Abstract][Full Text] [Related]
9. Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor.
Silverstein RL; Baird M; Lo SK; Yesner LM
J Biol Chem; 1992 Aug; 267(23):16607-12. PubMed ID: 1379600
[TBL] [Abstract][Full Text] [Related]
10. Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
Orecchia P; Conte R; Balza E; Pietra G; Mingari MC; Carnemolla B
Oncotarget; 2015 Nov; 6(35):37426-42. PubMed ID: 26460958
[TBL] [Abstract][Full Text] [Related]
11. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.
Koch M; Hussein F; Woeste A; Gründker C; Frontzek K; Emons G; Hawighorst T
Breast Cancer Res Treat; 2011 Jul; 128(2):337-46. PubMed ID: 20714802
[TBL] [Abstract][Full Text] [Related]
12. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.
Liu ZJ; Zhou YJ; Ding RL; Xie F; Fu SZ; Wu JB; Yang LL; Wen QL
PLoS One; 2018; 13(7):e0200845. PubMed ID: 30052652
[TBL] [Abstract][Full Text] [Related]
14. Contribution of cancer stem cells to tumor vasculogenic mimicry.
Yao XH; Ping YF; Bian XW
Protein Cell; 2011 Apr; 2(4):266-72. PubMed ID: 21533771
[TBL] [Abstract][Full Text] [Related]
15. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of norcantharidin on melanoma tumor growth and vasculogenic mimicry by suppressing MMP-2 expression.
Wang Z; You D; Lu M; He Y; Yan S
Oncol Lett; 2017 Mar; 13(3):1660-1664. PubMed ID: 28454306
[TBL] [Abstract][Full Text] [Related]
17. Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth.
Hale JS; Li M; Sinyuk M; Jahnen-Dechent W; Lathia JD; Silverstein RL
PLoS One; 2012; 7(7):e40033. PubMed ID: 22808089
[TBL] [Abstract][Full Text] [Related]
18. Vasculogenic mimicry: current status and future prospects.
Zhang S; Zhang D; Sun B
Cancer Lett; 2007 Sep; 254(2):157-64. PubMed ID: 17306454
[TBL] [Abstract][Full Text] [Related]
19. Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2).
Su F; Li B; Wang J; Xu X; Ren R; Li L; Gao F; Liu X
Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):411-9. PubMed ID: 19043732
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma.
Itzhaki O; Greenberg E; Shalmon B; Kubi A; Treves AJ; Shapira-Frommer R; Avivi C; Ortenberg R; Ben-Ami E; Schachter J; Besser MJ; Markel G
PLoS One; 2013; 8(2):e57160. PubMed ID: 23451174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
